0001140361-17-011290.txt : 20170309 0001140361-17-011290.hdr.sgml : 20170309 20170309191244 ACCESSION NUMBER: 0001140361-17-011290 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170307 FILED AS OF DATE: 20170309 DATE AS OF CHANGE: 20170309 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morton Andrew C. CENTRAL INDEX KEY: 0001498511 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 17679871 MAIL ADDRESS: STREET 1: C/O HANGER ORTHOPEDIC GROUP, INC. STREET 2: 10910 DOMAIN DRIVE, SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 4 1 doc1.xml FORM 4 X0306 4 2017-03-07 0 0000722723 HANGER, INC. HGR 0001498511 Morton Andrew C. 10910 DOMAIN DRIVE SUITE 300 AUSTIN TX 78758 0 1 0 0 SVP - Human Resources Common Stock 2017-03-07 4 F 0 347 13.87 D 38033 D Common Stock 2017-03-08 4 F 0 822 13.77 D 37211 D Common Stock 2017-03-08 4 A 0 8000 0 A 45211 D Reflects payment of tax liability by withholding shares of stock incident to vesting of restricted stock previously issued. Represents a grant of time-based restricted stock under the Company's 2016 Omnibus Incentive Plan (the "Plan"), which vests to the extent of 25% annually beginning on March 8, 2018 and cumulatively vests to the extent of 25% each year thereafter. The restricted stock being reported does not include the contingent right of the reporting person to receive up to 8,000 additional performance shares under the Plan based on the achievement of certain performance targets for the fiscal year 2017. Includes (i) unvested restricted shares which total 8,000 shares of stock from an initial grant of 8,000 shares of restricted stock that begins to vest on March 8, 2018; (ii) unvested restricted shares which total 5,000 shares of stock from an initial grant of 5,000 shares of restricted stock that begins to vest on October 11, 2017; (iii) unvested restricted shares and fully vested shares totaling 7,347 shares of stock from an initial grant of 8,000 shares of restricted stock that begins to vest on March 7, 2017; (iv) unvested restricted shares and fully vested shares totaling 4,619 shares of stock from an initial grant of 4,958 shares of restricted stock made on November 10, 2015; (v) unvested restricted shares and fully vested shares totaling 3,546 shares of stock from an initial grant of 4,239 shares of restricted stock made on March 6, 2015; [continued in next footnote] (vi) unvested restricted shares and fully vested shares totaling 1,557 shares of stock from an initial grant of 2,064 shares of restricted stock made on March 7, 2014;(vii) unvested restricted shares and fully vested shares totaling 2,987 shares of stock from an initial grant of 3,958 shares of restricted stock and performance shares made on March 11, 2013; (viii) fully vested shares totaling 2,930 shares of stock from an initial grant of 5,000 shares of restricted stock made on March 7, 2012; (ix) fully vested shares totaling 3,060 shares of stock from an initial grant of 4,900 shares of restricted stock made on March 25, 2011; and (x) fully vested shares totaling 6,165 shares of stock from an initial grant of 12,000 shares of restricted stock made on June 21, 2010. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. /s/ Jessica Lochmann Allen, Attorney-in-Fact for Andrew C. Morton 2017-03-09